header logo image


Page 519«..1020..518519520521..530540..»

Coronavirus and diabetes: the different risks for people with type 1 and type 2 – The Conversation UK

June 1st, 2020 6:48 pm

In early 2020, it seemed like people with diabetes were disproportionately dying with COVID-19, but the data provided more questions than answers. What type of diabetes did people have? Were people dying because the condition itself put them at greater risk, or because those with it tend to be older and have other illnesses? And what should people with diabetes do to protect themselves?

Now, researchers are harnessing data from NHS England to address these questions and some of their findings are unexpected.

It is still unclear whether people with diabetes are more likely to catch the virus. We wont know if this is true until sustained, widespread testing is rolled out. But we do know that a disproportionate number of people with the condition have been hospitalised with COVID-19. In the UK, data spanning February to April shows people with diabetes made up approximately 25% of hospitalised cases; thats almost four times higher than the estimated rate of diabetes in the general population.

Once in hospital with COVID-19, data also shows that people with diabetes have worse outcomes than people without. The increase in risk is striking but isnt necessarily surprising people with diabetes are prone to worse outcomes from infections generally, as data from flu shows.

When it comes to COVID-19, early studies suggest people with diabetes are approximately twice as likely to be categorised as having severe disease and are more likely to be admitted to intensive care units. In England, one in four people who die in hospital with COVID-19 have diabetes.

Previous studies, however, didnt shed light on the details behind these headline statistics, and didnt break down data by diabetes type. We now have this information, and it shows a significant and surprising difference.

Compared to people without diabetes, people with type 1 diabetes are approximately 3.5 times as likely to die in hospital with COVID-19, while people with type 2 are approximately twice as likely. This came as a surprise to some, because, unlike type 1, type 2 diabetes is often accompanied by other diseases, typically comes on in older age, and can be associated with raised body weight. All of these factors are linked to worse outcomes from COVID-19.

There are a number of possible explanations as to why outcomes are worse in type 1 compared to type 2.

First, the length of time someone has had diabetes might impact their vulnerability to COVID-19. Unlike type 2, people are most often diagnosed with type 1 at a young age (I was diagnosed at ten). In people hospitalised with COVID-19, someone with type 1 has likely had diabetes for much longer than someone with type 2. The longer someone has diabetes, the more likely they are to have complications, which include damage to the heart and kidneys.

Second, in type 1, your immune system attacks the cells that make insulin and you eventually stop making insulin altogether. Insulin is the hormone that helps the body process sugar in the blood. Type 2 isnt a disease of the immune system. In type 2, your body makes insulin but is resistant to it. The immune systems of people with type 1 may be different from people with type 2, which could impact how people respond to infection.

Finally, data shows that higher blood sugar levels increase the risk of COVID-19. We know that on average blood sugar levels are higher in people with type 1 than with type 2 diabetes, because of the different nature of the diseases. Blood sugar levels can be even harder to manage when fighting infections.

But these are all just theories. We need more research before we know for sure how the type of diabetes impacts COVID-19 outcomes.

To illustrate this, Im going to use myself as an example and do some crude calculations. Im 36 and have type 1 diabetes. Most people with COVID-19 arent hospitalised. However, if hospitalised with COVID-19, the average 36-year-old has a 0.3% chance of dying. Because I have type 1 diabetes, my chances of dying are 3.5 times higher. That means my current chances of dying with COVID-19 once hospitalised are around 1%.

However, if the average 80-year-old is hospitalised with COVID-19, they have a 15% chance of dying. So, though diabetes does increase my risk, my age still remains the most important factor, by far, in determining my chances of dying with COVID-19. My risk at 80 would still be higher than someone of that age without diabetes, so both would need to be taken into account.

It is really important to note that these figures are not someones overall risk of dying from COVID-19, they are the risk of dying if they contract COVID-19 and if the infection is then severe enough to warrant hospitalisation.

The advice to people with diabetes is to practice social distancing and handwashing like the rest of the population, to maintain a healthy lifestyle, and to try to keep blood sugars in an ideal range where possible.

But aiming for tighter blood sugar control can feel daunting. Now might be a particularly difficult time for people to manage diabetes, with disruptions in care, routines, activity, mental wellbeing and diet known to create challenges. Certain groups will face more challenges than others; both COVID-19 and diabetes disproportionately affect people from non-white ethnic groups and people from less advantaged backgrounds.

Support is available from healthcare providers and from organisations like Diabetes UK. Now more than ever, governments and healthcare systems need to ensure all people with diabetes get the support they need.

View original post here:
Coronavirus and diabetes: the different risks for people with type 1 and type 2 - The Conversation UK

Read More...

Pregnancy Loss Tied to Increased Risk of Type 2 Diabetes – The New York Times

June 1st, 2020 6:48 pm

Loss of a pregnancy may increase a womans risk of developing Type 2 diabetes, Danish researchers report.

Their study, in Diabetologia, included 24,774 women who developed diabetes after pregnancy and 247,740 controls who did not.

Compared with women who had been pregnant without losing a baby, those who lost one were at an 18 percent increased risk for diabetes, those who lost two were at a 38 percent higher risk and those who lost three or more had a 71 percent higher risk. The study adjusted for obesity and gestational diabetes, which are known to be associated with the development of Type 2 diabetes.

The reason for the association remains unknown. It may be that the same genetic background increases the risk for both pregnancy loss and diabetes, or that pre-diabetes present before the diagnosis of diabetes could lead to both. In any case, the authors stress that the observational finding does not prove cause and effect.

The lead author, Dr. Pia Egerup, a researcher at the Recurrent Pregnancy Loss Unit of the Rigshospitalet and Hvidovre Hospital in Copenhagen, said that the most important clinical implication is that pregnancy loss is a risk factor for diabetes.

Pregnancy loss is not only due to fetal disease, she said. A large proportion are healthy fetuses lost because of maternal conditions. As clinicians, we want to optimize pregnancy success and minimize the risk for future diabetes.

See the original post here:
Pregnancy Loss Tied to Increased Risk of Type 2 Diabetes - The New York Times

Read More...

FDA finds contamination in several brands of diabetes drug – ABC News

June 1st, 2020 6:48 pm

By

MATTHEW PERRONE AP Health Writer

May 29, 2020, 7:30 PM

2 min read

2 min read

WASHINGTON -- U.S. health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer.

The Food and Drug Administration said late Thursday that several batches of the drug metformin tested positive for unsafe levels of a chemical called N-Nitrosodimethylamine. The agency has stepped up testing after the chemical was found in dozens of shipments of heartburn drugs last year, triggering recalls of Zantac and other popular over-the-counter and prescription medications.

Metformin tablets are a staple of diabetes care, reducing excess sugar in the blood. People with Type 2 diabetes use metformin alone or with other drugs to help control their blood sugar levels. More than 34 million people in the U.S. have this disease.

Patients should continue taking metformin drugs until their doctor can prescribe a replacement, the FDA said in a statement, noting the risks of discontinuing. Regulators are still assessing whether the recalls will lead to shortages of metformin, but noted that a number of other companies make generic versions of the drugs that don't appear to be affected by the issue.

Drugmaker Apotex Corp. recalled its extended-release metformin distributed in the U.S. earlier this week after the FDA found contamination in one lot. Apotex said in a statement it recalled all supplies of the drug out of an abundance of caution. The company said it stopped selling the drug in the U.S. in February 2019 and that little remains on the market.

The FDA announcement did not name the four other drugmakers who have been requested to recall their products.

The agency noted that no contamination problems have been found in immediate-release metformin.

The FDA is responsible for ensuring that medicines for the U.S. market are made in safe, sanitary conditions that meet federal quality standards. But government inspectors have repeatedly criticized the agency for falling short in reviewing overseas manufacturing plants as the pharmaceutical supply chain has increasingly spread to Asia.

In March, the FDA suspended nearly all U.S. and foreign inspections due to safety concerns and travel restrictions caused by the coronavirus outbreak.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education. The AP is solely responsible for all content.

Go here to read the rest:
FDA finds contamination in several brands of diabetes drug - ABC News

Read More...

Men who had early puberty at higher risk of developing type 2 diabetes – TheHealthSite

June 1st, 2020 6:48 pm

The time of puberty onset may help predict the risk of diabetes in men. The earlier boys experienced the onset of puberty, the higher their risk of developing type 2 diabetes as adults, reveals a new study, published in the journal Diabetologia in March 2020. Also Read - 40% of diabetic patients initially decline insulin therapy: All you need to know about this disease

The findings may help establish guidelines for prevention and testing for diabetes in men. It may also lead to new interventions against the chronic condition that affects the way your body metabolizes sugar (glucose). Also Read - Trigger finger and other surprising signs of type 2 diabetes you might be ignoring so far

For the study, the researchers the University of Gothenburg in Sweden assessed more than 30,600 Swedish men born between 1945 and 1961. They found that those who had their pubertal growth spurt at age 9.3 to 13.4 years had a twofold risk of developing early type 2 diabetes than those who had the growth spurt at the age of 14.8 to 17.9 years. Also Read - Suffering from type 2 diabetes? Watch what youre eating for your breakfast

For each year earlier that the pubertal growth spurt occurred, the risk of developing early diabetes went up by 28 per cent, while the risk of late diabetes increased by 13 per cent. Men who had early pubertal growth spurt were also found to be more likely to require insulin treatment if they went on to develop type 2 diabetes.

While the researchers are not very clear about the underlying mechanisms of this association, they believe that that early puberty may lead to build-up of excess fat in the abdominal area. This may in turn leads to high blood pressure, diabetes, and abnormal lipid levels, which are all risk factors for cardiac and metabolic disease.

Earlier studies have already found an association between a high adult BMI and a higher risk for type 2 diabetes. It is also known that boys with a high BMI in childhood or during puberty have a greater diabetes risk. Some studies have also linked earlier onset of puberty in girls, as defined by the beginning of menstruation, to a higher risk of diabetes.

Jenny Kindblom, co-author of the new study, noted that their findings suggest that early puberty could be a novel independent risk factor for type 2 diabetes in men. She believes that a continuous monitoring of height and weight development during both childhood and adolescence may help identify individuals with increased risk of type of diabetes.

Type 2 diabetes occurs when your body either resists the effects of insulin or doesnt produce enough insulin to maintain normal glucose levels. Insulin is a hormone secreted by the pancreas and it helps regulate the movement of sugar into your cells.

Signs and symptoms of type 2 diabetes often develop gradually over time. They can be so mild that you can have type 2 diabetes for years and not know about it. Here are some symptoms to watch out for:

Unfortunately, theres no cure for type 2 diabetes. However, you can control the disease by maintaining a healthy weight, eating well and exercising. Some people may need diabetes medications or insulin therapy to manage their blood sugar levels.

Published : May 31, 2020 7:15 pm | Updated:June 1, 2020 8:13 am

Read the rest here:
Men who had early puberty at higher risk of developing type 2 diabetes - TheHealthSite

Read More...

This Diabetes Company’s Q1 Earnings Reflect the Resiliency of Its Business Model – The Motley Fool

June 1st, 2020 6:48 pm

Insulet(NASDAQ:PODD)earlier this month reported first-quarter 2020 results. The tubeless insulin pump specialist's results were quite strong, especially in light of the COVID-19 pandemic.

In 2020, shares of thehealthcare companyare up 10.2% through the end of May, outpacing the broader market, which is down about 5% because of the pandemic. Insulet stock remains a huge winner over the intermediate and long terms. Over the past five years, it's gained 567%, versus the broader market's 60% return.

Here's how the quarter worked out for Insulet and its investors.

Image source: Insulet.

Metric

Q1 2020

Q1 2019

Change

Revenue

Operating income

Net income

Earnings per share (EPS)

Data source: Insulet.

Revenue easily beat Insulet's guidance of growth of 17% to 20% year over year. For context, in the prior quarter, revenue grew 27% year over year.

The year-over-year decline on the bottom line was driven by an increase in interest expense.

Here's what CEO Shacey Petrovic had to say in the press release:

Insulet entered 2020 with positive momentum, making progress toward our strategic objectives and achieving strong revenue growth ahead of expectations. The efficiency and redundancy we have built in our supply chain and manufacturing operations enabled us to meet customer demand without interruption during this challenging time. We believe that our proven, durable annuity business model will continue to generate double-digit revenue growth in 2020. We remain confident we have the right strategic framework to effectively advance our mission, drive sustainable long-term growth throughout our global business, and to continue to create shareholder value.

On the earnings call, CFO McMillan quantified what Petrovic termed the company's "annuity business model," or what others might consider a razor-and-blade model: "Historically, new Omnipod starts within any given quarter contributed approximately 10% of revenue." In other words, the vast majority of quarterly revenue has come from existing Omnipod users purchasing new pods.

The Omnipod has no upfront cost, as it's a pay-as-you-go product, which means sales should hold up better in a recessionary environment relative to products that have considerable upfront costs.

Insulet's Q1 results were quite robust despite headwinds presented by the pandemic.

Unlike many companies, it didn't lower or pull its full-year 2020 guidance. Management reaffirmed its previously issued 2020 outlook of revenue growth of 14% to 18% over 2019. However, it did say that it now expects revenue to come in at the low end of this outlook. The company doesn't issue earnings guidance.

Due to the pandemic, Insulet's U.S. launch of its Omnipod Horizon automated insulin delivery system, which uses aDexCom(NASDAQ:DXCM) continuous glucose monitor (CGM) to dose insulin, has been pushed back. Management now expects this launch to occur in the first half of 2021, rather than in late 2020, Petrovic said on the earnings call.

Go here to read the rest:
This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model - The Motley Fool

Read More...

A New Book for Anyone With Type 1 Diabetes "Actually, I Can." by 19-year-old Author Gives Insight and Inspiration – PR Web

June 1st, 2020 6:48 pm

KATONAH, N.Y. (PRWEB) June 01, 2020

In her upcoming book Actually, I Can: Growing Up with Type 1 Diabetes, A Story of Unexpected Empowerment (T1D Media) Morgan Panzirer writes: It has made me appreciate every hour, every minute, and every second I stand on this Earth. But the truth is everyone should live this way, because you dont know if youll receive life-changing news tomorrow, and you dont know if today is your last day. Everyone has obstacles in their lives; its just the way life is. But you dont have to sit there and let them beat you down. Defeat them. Strength is a choice, and if you tell yourself you can get through whatever youre battling, then you can.

From the diagnosis at six years old with the autoimmune disease, through all of the challenges battling it, and everything she and her parents have learned Morgans goal is to help other families and children facing Type 1, and to show everyone it can be viewed as an opportunity rather than an obstacle.

Robin Roberts, co-Anchor Good Morning America, says: An inspiring young woman whose insight into her Type 1 diabetes will help others, and their families, to confront the vulnerabilities of the disease. Readers will learn from Morgan how to manage these issues with composure and strength.

Emmy-award winning medical correspondent and senior health editor for NBC, Dr. Max Gomez, explains: What I took away from Actually, I Can was not the charmed life, meeting celebrities and traveling the world. It was that after confronting the awfulness of her diagnosis, Morgan was able to face her disease and take control of it, including the difficult, painful ups and downs.

Founder of diaTribe.org Kelly L. Close reviews: This is a story about family, faith, and friendships, and includes remarkable encounters with politicians, pop stars, and even the Pope. Every teenager with diabetes should read this book. So, too, should their parents and their health care providers as well. A triumph.

Morgan has an authentic voice in the diabetes patient perspective. She unabashedly stares down and addresses the unrelenting challenges one faces in diabetes diagnosis and management, sans sugarcoating. Accompanied by gritty optimism, her impressive insight on progressing diabetes research, emerging tech and medications will impress readers with a resilient hope that a fulfilled and healthy life is possible, responds Gary Hall, Jr., first Olympian/Gold Medalist with Type One Diabetes.

About the AuthorA member of the Villanova University Equestrian Team, and a biology major planning to attend medical school for pediatric endocrinology, Morgan Panzirer has traveled the world discussing her disease, including a trip to Rome to meet with the Pope. Morgan is available as a keynote speaker and media presenter with invaluable information on Type 1 Diabetes, self-care and perseverance speaking to groups and offering copies of Actually, I Can. for the audience.

Share article on social media or email:

Read more here:
A New Book for Anyone With Type 1 Diabetes "Actually, I Can." by 19-year-old Author Gives Insight and Inspiration - PR Web

Read More...

COVID-19: Responding to the business impacts of Diabetes Care Drugs Market-Segment Market Trends, Analysis and Forecast 2019 2024 – Cole of Duty

June 1st, 2020 6:48 pm

The global Diabetes Care Drugs market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Diabetes Care Drugs market player in a comprehensive way. Further, the Diabetes Care Drugs market report emphasizes the adoption pattern of the Diabetes Care Drugs across various industries.

The Diabetes Care Drugs market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail.

The report on the Diabetes Care Drugs market provides a birds eye view of the current proceeding within the Diabetes Care Drugs market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Diabetes Care Drugs market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2554778&source=atm

The key players covered in this studyNovo NordiskSanofiEli LillyBioconAstraZenecaBristol Myers SquibbBoehringer IngelheimMylanPfizerJohnson & JohnsonMerckNovartisAstellasTeva

Market segment by Type, the product can be split intoOral Anti-diabetic DrugsInsulinsNon-insulin Injectable DrugsOther

Market segment by Application, split intoHospitalMedical Research InstituteClinicOther

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Diabetes Care Drugs status, future forecast, growth opportunity, key market and key players.To present the Diabetes Care Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetes Care Drugs are as follows:History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2554778&source=atm

The Diabetes Care Drugs market report offers a plethora of insights which include:

The Diabetes Care Drugs market report answers important questions which include:

The Diabetes Care Drugs market report considers the following years to predict the market growth:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2554778&licType=S&source=atm

Why Choose Diabetes Care Drugs Market Report?

Diabetes Care Drugs Market Reportfollows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

See the rest here:
COVID-19: Responding to the business impacts of Diabetes Care Drugs Market-Segment Market Trends, Analysis and Forecast 2019 2024 - Cole of Duty

Read More...

Visual Acuity: Is 20/20 Perfect Vision?

June 1st, 2020 6:47 pm

If you have aneye examand are told you have 20/20 vision, does this mean you have perfect eyesight? Is it possible to achieve even better than 20/20 vision? And what is "perfect vision" anyway?

To answer these questions, let's take a closer look at vision-related terminology to fully understand howeye doctorsmeasure the quality of your vision.

Visual acuity.This, literally, is the sharpness of your vision. Visual acuity is measured by your ability to identify letters or numbers on a standardizedeye chartfrom a specific viewing distance.

Visual acuity is a static measurement, meaning you are sitting still during the testing and the letters or numbers you are viewing also are stationary.

Visual acuity also is tested under high contrast conditions typically, the letters or numbers on the eye chart are black, and the background of the chart is white.

Although visual acuity testing is very useful to determine the relative clarity of your eyesight in standardized conditions, it isn't predictive of the quality of your vision in all situations. For example, it can't predict how well you would see:

Three major physical and neurological factors determine visual acuity:

How accurately thecorneaand lens of the eye focus light onto theretina

The sensitivity of the nerves in the retina and vision centers in the brain

The ability of the brain to interpret information received from the eyes

Only light that is focused on a very small and highly sensitive portion of the central retina (called themacula) influences visual acuity measurements obtained during an eye exam.

Visual acuity typically is quantified with Snellen fractions (see "What is 20/20 Vision?" below).

Eyesight.The exact definition of "eyesight" is difficult to pin down. Depending on which dictionary or other resource you check, it can mean "ability to see," "the sense of seeing," "vision," "range of sight" or "view." Often, the terms "eyesight" and "visual acuity" are used interchangeably.

Vision.This is a broader term than visual acuity or eyesight. In addition to sharpness of sight or simply a description of the ability to see, the term "vision" usually includes a wider range of visual abilities and skills. These includecontrast sensitivity, the ability to track moving objects with smooth and accurate eye movements,color vision, depth perception, focusing speed and accuracy, and more.

If this more inclusive (and accurate) definition of "vision" is used, what most people call "20/20 vision" should really be called "20/20 visual acuity." Realistically, that probably won't happen. For better or worse, the term "20/20 vision" is likely here to stay.

Advertisement

Glasses do more than improve your vision - they're an extension of your personality! Try this helpful quiz from EyeBuyDirect to guide you to the best fit for your unique style and personality. With high-tech lenses from the world's leading manufacturers and a completely risk-free 14-day free return policy, discovering your perfect pair has never been easier.

The term "20/20" and similar fractions (such as 20/40, 20/60, etc.) are visual acuity measurements. They also are called Snellen fractions, named after Herman Snellen, the Dutch ophthalmologist who developed this measurement system in 1862.

In the Snellen visual acuity system, the top number of the Snellen fraction is the viewing distance between the patient and the eye chart. In the United States, this distance typically is 20 feet; in other countries, it is 6 meters.

At this testing distance, the size of the letters on one of the smaller lines near the bottom of the eye chart has been standardized to correspond to "normal" visual acuity this is the "20/20" line. If you can identify the letters on this line but none smaller, you have normal (20/20) visual acuity.

The increasingly larger letter sizes on the lines on the Snellen chart above the 20/20 line correspond to worse visual acuity measurements (20/40, 20/60, etc.); the lines with smaller letters below the 20/20 line on the chart correspond to visual acuity measurements that are even better than 20/20 vision (e.g., 20/15, 20/12, 20/10).

The single big "E" at the top of most Snellen eye charts corresponds to 20/200 visual acuity. If this is the smallest letter size you can discern with your best corrective lenses in front of your eyes, you arelegally blind.

On most Snellen charts, the smallest letters correspond to 20/10 visual acuity. If you have 20/10 visual acuity, your eyesight is twice as sharp as that of a person with normal (20/20) vision.

Yes, it's indeed possible to have sharper than 20/20 vision. In fact, most people with young, healthy eyes are capable of identifying at least some of the letters on the 20/15 line or even smaller letters on the Snellen chart.

This may be due in part to better printing methods available today vs. those in the 19th century when Snellen was determining the smallest letters a person with normal vision should be able to discern. So a case could be made that "normal" visual acuity today is an ability to identify letters that are a bit smaller than those on the 20/20 line of a traditional Snellen eye chart.

On the other hand, people are living longer today than they did in Snellen's era. Normal aging changes in the eye, such as earlycataracts, could justify considering somewhat larger letters than those on the 20/20 line as being indicative of "normal" vision among adults in their 60s or older.

Regardless of these considerations, let's say your eye doctor says you have 20/20 vision (or, more accurately, 20/20 visual acuity), and you want sharper eyesight. What can you do?

If your 20/20 vision doesn't seem sharp enough, it could be that your eyes havehigher-order aberrations (HOAs)that cannot be corrected with regular eyeglasses or soft contact lenses. Your eye doctor can check for these aberrations withwavefront technologythat is available in some eye care practices.

If HOAs are caused by small irregularities in the shape of the front surface of your eyes, being fitted withgas permeable contact lenses (GP lenses)often can improve your visual acuity better than eyeglasses or soft contact lenses. This is because GP lenses are rigid and essentially replace the eye's irregular front surface with a perfectly smooth, curved surface to focus light more accurately.

Another option might becustom wavefront LASIK. This personalized laser vision correction surgery can provide vision that is comparable to wearing rigid gas permeable contact lenses (which often is sharper than the visual acuity provided by glasses or soft contact lenses), without the hassle of the daily contact lens care.

If you prefer to wear eyeglasses to correct your refractive errors, glasses with specialhigh-definition lenses might give you sharper vision than regular eyeglass lenses.

It's nearly impossible to quantify what "perfect" vision is. A more interesting question is, "Perfect for what?"

For example, if you are driving on a sunny day, excellent Snellen visual acuity might be the main factor in your satisfaction with your vision. But your traveling companion, who has worse visual acuity than yours, might be happier with her vision in the same circumstances because she is wearing polarized sunglasses with anti-reflective coating that enhance contrast and block glare.

Or an athlete who has better than 20/20 vision might struggle with his performance because he doesn't have certain dynamic visual skills that allow him to react to moving objects as quickly as a teammate whose static visual acuity isn't as sharp as his.

The first step to maximizing the clarity and comfort of your eyesight in all situations is to see a qualified optometrist orophthalmologistfor a comprehensive eye exam and vision evaluation.

If you are interested in finding out if laser vision correction could sharpen your vision better than glasses or contacts, ask to be referred to an experiencedLASIK surgeonfor a consultation.

If you want to maximize your dynamic vision skills for sports and other activities, seek an eye doctor who is a sports vision specialist and ask aboutsports vision training.

Finally, if your child has 20/20 vision but is struggling with eye strain and other vision problems in school, seek the advice of an eye care provider who specializes in children's vision to have your child evaluated for possiblelearning-related vision problems.

Ready to have your eyes checked? Find an eye doctor near you.

Page updated April 2019

Read more:
Visual Acuity: Is 20/20 Perfect Vision?

Read More...

9 Serious Vision Symptoms to Watch Out For | Everyday Health

June 1st, 2020 6:47 pm

1. Flashing Lights, Floaters, or a Gray Shadow in Your Vision

The sudden onset of flashing lights, a noticeable increase in the amount of floaters, a shadow in your peripheral vision, or a gray curtain moving across your field of vision could be signs of a detachment of the retina the nerve layer in the back of the eye that sends images to the brain. Nearsightedness, eye diseases like glaucoma, and physical injury to the eye are among the causes of retinal detachment. Unless treated quickly, usually with surgery, retinal detachment can lead to blindness.

Sudden vision loss could signal a number of eye diseases and conditions. One is macular degeneration, also known as age-related macular degeneration or AMD, which is a leading cause of vision loss in people 65 and older in the United States. Vision loss caused by AMD can be gradual, but in some cases it can be sudden when blood vessels in the eye leak fluid or blood under the retina, which is made up of nerve cells that allow you to see.

Another cause of sudden vision loss could be a type of glaucoma, which leads to a rapid buildup of fluid pressure in the eye that damages the optic nerve. There are many other conditions that can cause persistentloss of vision.

Most eye diseases are painless, but some conditions or injuries can result in eye pain, says Richard Shugarman, MD, an ophthalmologist in West Palm Beach, Florida. Eye pain can be caused by glaucoma,dry eye, an eye injury, a scratched cornea, or even cancer of the eye.

Any significantinjury to the eyeshould be evaluated by a doctor, particularly if there is redness or pain that lasts for more than 15 to 20 minutes.

If you experience any discomfort in your eye after doing an activity in which a small particle could have entered your eye, such as hammering or working under a car, dont ignore it. Have your eyes checked out by a doctor to make sure that you dont have a foreign particle in the eye, which can cause an infection.

Having two red eyes is probably not as serious as one red eye, says Dr. Shurgarman. When both eyes are red at the same time, it could be a sign of a cold orconjunctivitis (pink eye) minor infections that are self-healing. But one red eye can be an indicator of a deeper inflammation, such as scleritis or uveitis. Scleritis is the inflammation of the tough, outer protective barrier around the eye, and uveitis is the inflammation and swelling of the middle coating of the eyeball.

While most people who use contact lenses dont experience problems when they follow the rules of proper contact lens care and use, serious infections can occasionally occur. If you wear contact lenses, never ignore eye pain, redness, or discomfort see an eye doctor right away.

Even if it clears up, blurred vision can be a sign of a number of eye problems, such as glaucoma, uveitis, a torn retina, or AMD. Losing vision in one eye may be an early symptom of astroke. Vision loss, especially in one eye, could be a sign that the carotid artery, which is a major supplier of blood to the eyes, is blocked, says Shugarman.

If youve had eye surgery and experience any redness, eye pain, or blurring of vision, call your doctor right away for an evaluation.

Even if a symptom appears to go away, youre better off checking with your eye specialist if you encounter any of these warning signs.

Here is the original post:
9 Serious Vision Symptoms to Watch Out For | Everyday Health

Read More...

Visual acuity – Wikipedia

June 1st, 2020 6:47 pm

"6/6" redirects here. For the date, see June 6.

Visual acuity (VA) commonly refers to the clarity of vision, but technically rates an examinee's ability to recognize small details with precision. Visual acuity is dependent on optical and neural factors, i.e., (1) the sharpness of the retinal focus within the eye, (2) the health and functioning of the retina, and (3) the sensitivity of the interpretative faculty of the brain.[1]

A common cause of low visual acuity is refractive error (ametropia), errors in how the light is refracted in the eyeball, and errors in how light entering the eye is interpreted by the brain. The latter is the primary cause for low vision in people with albinism. . Causes of refractive errors include aberrations in the shape of the eyeball or the cornea, and reduced flexibility of the lens. Too high or too low refractive error (in relation to the length of the eyeball) is the cause of nearsightedness (myopia) or farsightedness (hyperopia) (normal refractive status is referred to as emmetropia). Other optical causes are astigmatism or more complex corneal irregularities. These anomalies can mostly be corrected by optical means (such as eyeglasses, contact lenses, laser surgery, etc.).

Neural factors that limit acuity are located in the retina or the brain (or the pathway leading there). Examples for the first are a detached retina and macular degeneration, to name just two. Another common impairment, amblyopia, is caused by the visual brain not having developed properly in early childhood. In some cases, low visual acuity is caused by brain damage, such as from traumatic brain injury or stroke. When optical factors are corrected for, acuity can be considered a measure of neural well-functioning.

Visual acuity is typically measured while fixating, i.e. as a measure of central (or foveal) vision, for the reason that it is highest there. However, acuity in peripheral vision can be of equal (or sometimes higher) importance in everyday life. Acuity declines towards the periphery in an inverse-linear fashion (i.e. the decline follows approximately a hyperbola).[2][3] The decline is according to E2/(E2+E), where E is eccentricity in degrees visual angle[verification needed], and E2 is a constant of approximately 2 deg[4][5][6]. At 2 deg eccentricity, for example, acuity is half the foveal value. The visual acuity standard does not recognize an examinee's ability to recognize large objects or symbols that are exceed the size and quality offered by a standard exam. Nor can visual acuity alone cannot determine the over all quality visual function.

Visual acuity is a measure of the spatial resolution of the visual processing system. VA, as it is sometimes referred to by optical professionals, is tested by requiring the person whose vision is being tested to identify so-called optotypes stylized letters, Landolt rings, pediatric symbols, symbols for the illiterate, standardized Cyrillic letters in the GolovinSivtsev table, or other patterns on a printed chart (or some other means) from a set viewing distance. Optotypes are represented as black symbols against a white background (i.e. at maximum contrast). The distance between the person's eyes and the testing chart is set so as to approximate "optical infinity" in the way the lens attempts to focus (far acuity), or at a defined reading distance (near acuity).

A reference value above which visual acuity is considered normal is called 6/6 vision, the USC equivalent of which is 20/20 vision: At 6 metres or 20 feet, a human eye with that performance is able to separate contours that are approximately 1.75 mm apart.[7] Vision of 6/12 corresponds to lower performance, while vision of 6/3 to better performance. Normal individuals have an acuity of 6/4 or better (depending on age and other factors).

In the expression 6/x vision, the numerator (6) is the distance in metres between the subject and the chart and the denominator (x) the distance at which a person with 6/6 acuity would discern the same optotype. Thus, 6/12 means that a person with 6/6 vision would discern the same optotype from 12 metres away (i.e. at twice the distance). This is equivalent to saying that with 6/12 vision, the person possesses half the spatial resolution and needs twice the size to discern the optotype.

A simple and efficient way to state acuity is by converting the fraction to a decimal: 6/6 then corresponds to an acuity (or a Visus) of 1.0 (see Expression below), while 6/3 corresponds to 2.0, which is often attained by well-corrected healthy young subjects with binocular vision. Stating acuity as a decimal number is the standard in European countries, as required by the European norm (EN ISO 8596, previously DIN 58220).

The precise distance at which acuity is measured is not important as long as it is sufficiently far away and the size of the optotype on the retina is the same. That size is specified as a visual angle, which is the angle, at the eye, under which the optotype appears. For 6/6 = 1.0 acuity, the size of a letter on the Snellen chart or Landolt C chart is a visual angle of 5 arc minutes (1 arc min = 1/60 of a degree). By the design of a typical optotype (like a Snellen E or a Landolt C), the critical gap that needs to be resolved is 1/5 this value, i.e., 1 arc min. The latter is the value used in the international definition of visual acuity:

Acuity is a measure of visual performance and does not relate to the eyeglass prescription required to correct vision. Instead, an eye exam seeks to find the prescription that will provide the best corrected visual performance achievable. The resulting acuity may be greater or less than 6/6 = 1.0. Indeed, a subject diagnosed as having 6/6 vision will often actually have higher visual acuity because, once this standard is attained, the subject is considered to have normal (in the sense of undisturbed) vision and smaller optotypes are not tested. Subjects with 6/6 vision or "better" (20/15, 20/10, etc.) may still benefit from an eyeglass correction for other problems related to the visual system, such as hyperopia, ocular injuries, or presbyopia.

Visual acuity is measured by a psychophysical procedure and as such relates the physical characteristics of a stimulus to a subject's percept and his/her resulting responses. Measurement can be by using an eye chart invented by Ferdinand Monoyer, by optical instruments, or by computerized tests[8] like the FrACT.[9]

Care must be taken that viewing conditions correspond to the standard,[10] such as correct illumination of the room and the eye chart, correct viewing distance, enough time for responding, error allowance, and so forth. In European countries, these conditions are standardized by the European norm (EN ISO 8596, previously DIN 58220).

Theodor Wertheim in Berlin presents detailed measurements of acuity in peripheral vision.[2][15]

Hugh Taylor uses these design principles for a "Tumbling E Chart" for illiterates, later used[16] to study the visual acuity of Australian Aborigines.[12]

Rick Ferris et al. of the National Eye Institute chooses the LogMAR chart layout, implemented with Sloan letters, to establish a standardized method of visual acuity measurement for the Early Treatment of Diabetic Retinopathy Study (ETDRS).These charts are used in all subsequent clinical studies, and did much to familiarize the profession with the new layout and progression. Data from the ETDRS were used to select letter combinations that give each line the same average difficulty, without using all letters on each line.

The International Council of Ophthalmology approves a new 'Visual Acuity Measurement Standard', also incorporating the above features.

Antonio Medina and Bradford Howland of the Massachusetts Institute of Technology develop a novel eye testing chart using letters that become invisible with decreasing acuity, rather than blurred as in standard charts. They demonstrate the arbitrary nature of the Snellen fraction and warn about the accuracy of visual acuity determined by using charts of different letter types, calibrated by Snellen's system.[17]

Daylight vision (i.e. photopic vision) is subserved by cone receptor cells which have high spatial density (in the central fovea) and allow high acuity of 6/6 or better. In low light (i.e., scotopic) vision, cones do not have sufficient sensitivity and vision is subserved by rods. Spatial resolution is then much lower. This is due to spatial summation of rods, i.e. a number of rods merge into a bipolar cell, in turn connecting to a ganglion cell, and the resulting unit for resolution is large, and acuity small. Note that there are no rods in the very center of the visual field (the foveola), and highest performance in low light is achieved in near peripheral vision[2]

The maximum angular resolution of the human eye is 28 arc seconds or 0.47 arc minutes,[18] this gives an angular resolution of 0.008 degrees, and at a distance of 1km corresponds to 136mm. This is equal to 0.94 arc minutes per line pair (one white and one black line), or 0.016 degrees. For a pixel pair (one white and one black pixel) this gives a pixel density of 128 pixels per degree (PPD).

6/6 vision is defined as the ability to resolve two points of light separated by a visual angle of one minute of arc, corresponding to 60 PPD, or about 290350 pixels per inch for a display on a device held 250 to 300mm from the eye.[19]

Thus, visual acuity, or resolving power (in daylight, central vision), is the property of cones.[20]To resolve detail, the eye's optical system has to project a focused image on the fovea, a region inside the macula having the highest density of cone photoreceptor cells (the only kind of photoreceptors existing in the fovea's very center of 300 m diameter), thus having the highest resolution and best color vision. Acuity and color vision, despite being mediated by the same cells, are different physiologic functions that do not interrelate except by position. Acuity and color vision can be affected independently.

The grain of a photographic mosaic has just as limited resolving power as the "grain" of the retinal mosaic. To see detail, two sets of receptors must be intervened by a middle set. The maximum resolution is that 30 seconds of arc, corresponding to the foveal cone diameter or the angle subtended at the nodal point of the eye. To get reception from each cone, as it would be if vision was on a mosaic basis, the "local sign" must be obtained from a single cone via a chain of one bipolar, ganglion, and lateral geniculate cell each. A key factor of obtaining detailed vision, however, is inhibition. This is mediated by neurons such as the amacrine and horizontal cells, which functionally render the spread or convergence of signals inactive. This tendency to one-to-one shuttle of signals is powered by brightening of the center and its surroundings, which triggers the inhibition leading to a one-to-one wiring. This scenario, however, is rare, as cones may connect to both midget and flat (diffuse) bipolars, and amacrine and horizontal cells can merge messages just as easily as inhibit them.[7]

Light travels from the fixation object to the fovea through an imaginary path called the visual axis. The eye's tissues and structures that are in the visual axis (and also the tissues adjacent to it) affect the quality of the image. These structures are: tear film, cornea, anterior chamber, pupil, lens, vitreous, and finally the retina. The posterior part of the retina, called the retinal pigment epithelium (RPE) is responsible for, among many other things, absorbing light that crosses the retina so it cannot bounce to other parts of the retina. In many vertebrates, such as cats, where high visual acuity is not a priority, there is a reflecting tapetum layer that gives the photoreceptors a "second chance" to absorb the light, thus improving the ability to see in the dark. This is what causes an animal's eyes to seemingly glow in the dark when a light is shone on them. The RPE also has a vital function of recycling the chemicals used by the rods and cones in photon detection. If the RPE is damaged and does not clean up this "shed" blindness can result.

As in a photographic lens, visual acuity is affected by the size of the pupil. Optical aberrations of the eye that decrease visual acuity are at a maximum when the pupil is largest (about 8mm), which occurs in low-light conditions. When the pupil is small (12mm), image sharpness may be limited by diffraction of light by the pupil (see diffraction limit). Between these extremes is the pupil diameter that is generally best for visual acuity in normal, healthy eyes; this tends to be around 3 or 4mm.

If the optics of the eye were otherwise perfect, theoretically, acuity would be limited by pupil diffraction, which would be a diffraction-limited acuity of 0.4 minutes of arc (minarc) or 6/2.6 acuity. The smallest cone cells in the fovea have sizes corresponding to 0.4 minarc of the visual field, which also places a lower limit on acuity. The optimal acuity of 0.4 minarc or 6/2.6 can be demonstrated using a laser interferometer that bypasses any defects in the eye's optics and projects a pattern of dark and light bands directly on the retina. Laser interferometers are now used routinely in patients with optical problems, such as cataracts, to assess the health of the retina before subjecting them to surgery.

The visual cortex is the part of the cerebral cortex in the posterior part of the brain responsible for processing visual stimuli, called the occipital lobe. The central 10 of field (approximately the extension of the macula) is represented by at least 60% of the visual cortex. Many of these neurons are believed to be involved directly in visual acuity processing.

Proper development of normal visual acuity depends on a human or an animal having normal visual input when it is very young. Any visual deprivation, that is, anything interfering with such input over a prolonged period of time, such as a cataract, severe eye turn or strabismus, anisometropia (unequal refractive error between the two eyes), or covering or patching the eye during medical treatment, will usually result in a severe and permanent decrease in visual acuity and pattern recognition in the affected eye if not treated early in life, a condition known as amblyopia. The decreased acuity is reflected in various abnormalities in cell properties in the visual cortex. These changes include a marked decrease in the number of cells connected to the affected eye as well as cells connected to both eyes in cortical area V1, resulting in a loss of stereopsis, i.e. depth perception by binocular vision (colloquially: "3D vision"). The period of time over which an animal is highly sensitive to such visual deprivation is referred to as the critical period.

The eye is connected to the visual cortex by the optic nerve coming out of the back of the eye. The two optic nerves come together behind the eyes at the optic chiasm, where about half of the fibers from each eye cross over to the opposite side and join fibers from the other eye representing the corresponding visual field, the combined nerve fibers from both eyes forming the optic tract. This ultimately forms the physiological basis of binocular vision. The tracts project to a relay station in the midbrain called the lateral geniculate nucleus, part of the thalamus, and then to the visual cortex along a collection of nerve fibers called the optic radiation.

Any pathological process in the visual system, even in older humans beyond the critical period, will often cause decreases in visual acuity. Thus measuring visual acuity is a simple test in accessing the health of the eyes, the visual brain, or pathway to the brain. Any relatively sudden decrease in visual acuity is always a cause for concern. Common causes of decreases in visual acuity are cataracts and scarred corneas, which affect the optical path, diseases that affect the retina, such as macular degeneration and diabetes, diseases affecting the optic pathway to the brain such as tumors and multiple sclerosis, and diseases affecting the visual cortex such as tumors and strokes.

Though the resolving power depends on the size and packing density of the photoreceptors, the neural system must interpret the receptors information. As determined from single-cell experiments on the cat and primate, different ganglion cells in the retina are tuned to different spatial frequencies, so some ganglion cells at each location have better acuity than others. Ultimately, however, it appears that the size of a patch of cortical tissue in visual area V1 that processes a given location in the visual field (a concept known as cortical magnification) is equally important in determining visual acuity. In particular, that size is largest in the fovea's center, and decreases with increasing distance from there.[2]

Besides the neural connections of the receptors, the optical system is an equally key player in retinal resolution. In the ideal eye, the image of a diffraction grating can subtend 0.5 micrometre on the retina. This is certainly not the case, however, and furthermore the pupil can cause diffraction of the light. Thus, black lines on a grating will be mixed with the intervening white lines to make a gray appearance. Defective optical issues (such as uncorrected myopia) can render it worse, but suitable lenses can help. Images (such as gratings) can be sharpened by lateral inhibition, i.e., more highly excited cells inhibiting the less excited cells. A similar reaction is in the case of chromatic aberrations, in which the color fringes around black-and-white objects are inhibited similarly.[7]

Visual acuity is often measured according to the size of letters viewed on a Snellen chart or the size of other symbols, such as Landolt Cs or the E Chart.

In some countries, acuity is expressed as a vulgar fraction, and in some as a decimal number.

Using the metre as a unit of measurement, (fractional) visual acuity is expressed relative to 6/6. Otherwise, using the foot, visual acuity is expressed relative to 20/20. For all practical purposes, 20/20 vision is equivalent to 6/6. In the decimal system, acuity is defined as the reciprocal value of the size of the gap (measured in arc minutes) of the smallest Landolt C, the orientation of which can be reliably identified. A value of 1.0 is equal to 6/6.

LogMAR is another commonly used scale, expressed as the (decadic) logarithm of the minimum angle of resolution (MAR). The LogMAR scale converts the geometric sequence of a traditional chart to a linear scale. It measures visual acuity loss: positive values indicate vision loss, while negative values denote normal or better visual acuity. This scale is commonly used clinically and in research because the lines are of equal length and so it forms a continuous scale with equally spaced intervals between points, unlike snellen charts which have different numbers of letters on each line.

A visual acuity of 6/6 is frequently described as meaning that a person can see detail from 6 metres (20ft) away the same as a person with "normal" eyesight would see from 6 metres. If a person has a visual acuity of 6/12, he is said to see detail from 6 metres (20ft) away the same as a person with "normal" eyesight would see it from 12 metres (39ft) away.

Healthy young observers may have a binocular acuity superior to 6/6; the limit of acuity in the unaided human eye is around 6/36/2.4 (20/1020/8), although 6/3 was the highest score recorded in a study of some US professional athletes.[26] Some birds of prey, such as hawks, are believed to have an acuity of around 20/2;[27] in this respect, their vision is much better than human eyesight.

When visual acuity is below the largest optotype on the chart, the reading distance is reduced until the patient can read it. Once the patient is able to read the chart, the letter size and test distance are noted. If the patient is unable to read the chart at any distance, he or she is tested as follows:

For example, the recording CF 5' would mean the patient was able to count the examiner's fingers from a maximum distance of 5 feet directly in front of the examiner.

(The results of this test, on the same patient, may vary from examiner to examiner. This is due more so to the size differences of the various examiner's hands and fingers, than fluctuating vision.)

For example, the recording HM 2' would mean that the patient was able to distinguish movement of the examiner's hand from a maximum distance of 2feet directly in front of the examiner.

(The results of the Hand Motion test are often recorded without the testing distance. This is due to the fact that this test is performed after the patient cannot "pass" the Counting Fingers test. At this point, the examiner is usually directly in front of the patient, and it is assumed that the Hand Motion test is performed at a testing distance of 1 foot or less.)

Various countries have defined statutory limits for poor visual acuity that qualifies as a disability. For example, in Australia, the Social Security Act defines blindness as:

A person meets the criteria for permanent blindness under section 95 of the Social Security Act if the corrected visual acuity is less than 6/60 on the Snellen Scale in both eyes or there is a combination of visual defects resulting in the same degree of permanent visual loss.[28]

In the US, the relevant federal statute defines blindness as follows:[29]

[T]he term "blindness" means central visual acuity of 20/200 or less in the better eye with the use of a correcting lens. An eye that is accompanied by a limitation in the fields of vision such that the widest diameter of the visual field subtends an angle no greater than 20 degrees shall be considered for purposes in this paragraph as having a central visual acuity of 20/200 or less.

A person's visual acuity is registered documenting the following: whether the test was for distant or near vision, the eye(s) evaluated and whether corrective lenses (i.e. glasses or contact lenses) were used:

So, distant visual acuity of 6/10 and 6/8 with pinhole in the right eye will be: DscOD 6/10 PH 6/8. Distant visual acuity of count fingers and 6/17 with pinhole in the left eye will be: DscOS CF PH 16/17. Near visual acuity of 6/8 with pinhole remaining at 6/8 in both eyes with spectacles will be: NccOU 6/8 PH 6/8.

"Dynamic visual acuity" defines the ability of the eye to visually discern fine detail in a moving object.

Visual acuity measurement involves more than being able to see the optotypes. The patient should be cooperative, understand the optotypes, be able to communicate with the physician, and many more factors. If any of these factors is missing, then the measurement will not represent the patient's real visual acuity.

Visual acuity is a subjective test meaning that if the patient is unwilling or unable to cooperate, the test cannot be done. A patient who is sleepy, intoxicated, or has any disease that can alter their consciousness or mental status, may not achieve their maximum possible acuity.

Illiterate patients who cannot read letters and/or numbers will be registered as having very low visual acuity if this is not known. Some patients will not tell the examiner that they do not know the optotypes, unless asked directly about it. Brain damage can result in a patient not being able to recognize printed letters, or being unable to spell them.

A motor inability can make a person respond incorrectly to the optotype shown and negatively affect the visual acuity measurement.

Variables such as pupil size, background adaptation luminance, duration of presentation, type of optotype used, interaction effects from adjacent visual contours (or crowding") can all affect visual acuity measurement.

The newborns visual acuity is approximately 6/133, developing to 6/6 well after the age of six months in most children, according to a study published in 2009.[30]

The measurement of visual acuity in infants, pre-verbal children and special populations (for instance, handicapped individuals) is not always possible with a letter chart. For these populations, specialised testing is necessary. As a basic examination step, one must check whether visual stimuli can be fixated, centered and followed.

More formal testing using preferential looking techniques use Teller acuity cards (presented by a technician from behind a window in the wall) to check whether the child is more visually attentive to a random presentation of vertical or horizontal gratings on one side compared with a blank page on the other side the bars become progressively finer or closer together, and the endpoint is noted when the child in its adult carer's lap equally prefers the two sides.

Another popular technique is electro-physiologic testing using visual evoked (cortical) potentials (VEPs or VECPs), which can be used to estimate visual acuity in doubtful cases and expected severe vision loss cases like Leber's congenital amaurosis.

VEP testing of acuity is somewhat similar to preferential looking in using a series of black and white stripes (sine wave gratings) or checkerboard patterns (which produce larger responses than stripes). Behavioral responses are not required and brain waves created by the presentation of the patterns are recorded instead. The patterns become finer and finer until the evoked brain wave just disappears, which is considered to be the endpoint measure of visual acuity. In adults and older, verbal children capable of paying attention and following instructions, the endpoint provided by the VEP corresponds very well to the psychophysical measure in the standard measurement (i.e. the perceptual endpoint determined by asking the subject when they can no longer see the pattern). There is an assumption that this correspondence also applies to much younger children and infants, though this does not necessarily have to be the case. Studies do show the evoked brain waves, as well as derived acuities, are very adult-like by one year of age.

For reasons not totally understood, until a child is several years old, visual acuities from behavioral preferential looking techniques typically lag behind those determined using the VEP, a direct physiological measure of early visual processing in the brain. Possibly it takes longer for more complex behavioral and attentional responses, involving brain areas not directly involved in processing vision, to mature. Thus the visual brain may detect the presence of a finer pattern (reflected in the evoked brain wave), but the "behavioral brain" of a small child may not find it salient enough to pay special attention to.

A simple but less-used technique is checking oculomotor responses with an optokinetic nystagmus drum, where the subject is placed inside the drum and surrounded by rotating black and white stripes. This creates involuntary abrupt eye movements (nystagmus) as the brain attempts to track the moving stripes. There is a good correspondence between the optokinetic and usual eye-chart acuities in adults. A potentially serious problem with this technique is that the process is reflexive and mediated in the low-level brain stem, not in the visual cortex. Thus someone can have a normal optokinetic response and yet be cortically blind with no conscious visual sensation.

Visual acuity depends upon how accurately light is focused on the retina, the integrity of the eye's neural elements, and the interpretative faculty of the brain.[31] "Normal" visual acuity (in central, i.e. foveal vision) is frequently considered to be what was defined by Herman Snellen as the ability to recognize an optotype when it subtended 5 minutes of arc, that is Snellen's chart 6/6-metre, 20/20 feet, 1.00 decimal or 0.0 logMAR. In young humans, the average visual acuity of a healthy, emmetropic eye (or ametropic eye with correction) is approximately 6/5 to 6/4, so it is inaccurate to refer to 6/6 visual acuity as "perfect" vision. 6/6 is the visual acuity needed to discriminate two contours separated by 1 arc minute 1.75mm at 6 metres. This is because a 6/6 letter, E for example, has three limbs and two spaces in between them, giving 5 different detailed areas. The ability to resolve this therefore requires 1/5 of the letter's total size, which in this case would be 1 minute of arc (visual angle). The significance of the 6/6 standard can best be thought of as the lower limit of normal, or as a screening cutoff. When used as a screening test, subjects that reach this level need no further investigation, even though the average visual acuity with a healthy visual system is typically better.

Some people may suffer from other visual problems, such as severe visual field defects, color blindness, reduced contrast, mild amblyopia, cerebral visual impairments, inability to track fast-moving objects, or one of many other visual impairments and still have "normal" visual acuity. Thus, "normal" visual acuity by no means implies normal vision. The reason visual acuity is very widely used is that it is easily measured, its reduction (after correction) often indicates some disturbance, and that it often corresponds with the normal daily activities a person can handle, and evaluates their impairment to do them (even though there is heavy debate over that relationship).

Normally, visual acuity refers to the ability to resolve two separated points or lines, but there are other measures of the ability of the visual system to discern spatial differences.

Vernier acuity measures the ability to align two line segments. Humans can do this with remarkable accuracy. This success is sometimes regarded as hyperacuity. Under optimal conditions of good illumination, high contrast, and long line segments, the limit to vernier acuity is about 8 arc seconds or 0.13 arc minutes, compared to about 0.6 arc minutes (6/4) for normal visual acuity or the 0.4 arc minute diameter of a foveal cone. Because the limit of vernier acuity is well below that imposed on regular visual acuity by the "retinal grain" or size of the foveal cones, it is thought to be a process of the visual cortex rather than the retina. Supporting this idea, vernier acuity seems to correspond very closely (and may have the same underlying mechanism) enabling one to discern very slight differences in the orientations of two lines, where orientation is known to be processed in the visual cortex.

The smallest detectable visual angle produced by a single fine dark line against a uniformly illuminated background is also much less than foveal cone size or regular visual acuity. In this case, under optimal conditions, the limit is about 0.5 arc seconds or only about 2% of the diameter of a foveal cone. This produces a contrast of about 1% with the illumination of surrounding cones. The mechanism of detection is the ability to detect such small differences in contrast or illumination, and does not depend on the angular width of the bar, which cannot be discerned. Thus as the line gets finer, it appears to get fainter but not thinner.

Stereoscopic acuity is the ability to detect differences in depth with the two eyes. For more complex targets, stereoacuity is similar to normal monocular visual acuity, or around 0.61.0 arc minutes, but for much simpler targets, such as vertical rods, may be as low as only 2 arc seconds. Although stereoacuity normally corresponds very well with monocular acuity, it may be very poor, or absent, even in subjects with normal monocular acuities. Such individuals typically have abnormal visual development when they are very young, such as an alternating strabismus, or eye turn, where both eyes rarely, or never, point in the same direction and therefore do not function together.

The eye has acuity limits for detecting motion.[32] Forward motion is limited by the subtended angular velocity detection threshold (SAVT), and horizontal and vertical motion acuity are limited by lateral motion thresholds. The lateral motion limit is generally below the looming motion limit, and for an object of a given size, lateral motion becomes the more insightful of the two, once the observer moves sufficiently far away from the path of travel. Below these thresholds subjective constancy is experienced in accordance with the Stevens' power law and WeberFechner law.

There is a specific acuity limit in detecting an approaching object's looming motion.[33][34] This is regarded as the subtended angular velocity detection threshold (SAVT) limit of visual acuity.[35] It has a practical value of 0.0275 rad/s.[36] For a person with SAVT limit of t {displaystyle {dot {theta }}_{t}} , the looming motion of a directly approaching object of size S, moving at velocity v, is not delectable until its distance D is[33]

where the S2/4 term is omitted for small objects relative to great distances by small-angle approximation.

To exceed the SAVT, an object of size S moving as velocity v must be closer than D; beyond that distance, subjective constancy is experienced. The SAVT t {displaystyle {dot {theta }}_{t}} can be measured from the distance at which a looming object is first detected:

where the S2 term is omitted for small objects relative to great distances by small-angle approximation.

The SAVT has the same kind of importance to driving safety and sports as the static limit. The formula is derived from taking the derivative of the visual angle with respect to distance, and then multiplying by velocity to obtain the time rate of visual expansion (d/dt = d/dx dx/dt).

There are acuity limits ( t {displaystyle {dot {theta }}_{t}} ) of horizontal and vertical motion as well.[32] They can be measured and defined by the threshold detection of movement of an object traveling at distance D and velocity v orthogonal to the direction of view, from a set-back distance B with the formula

Because the tangent of the subtended angle is the ratio of the orthogonal distance to the set-back distance, the angular time rate (rad/s) of lateral motion is simply the derivative of the inverse tangent multiplied by the velocity (d/dt = d/dx dx/dt). In application this means that an orthogonally traveling object will not be discernible as moving until it has reached the distance

where t {displaystyle {dot {theta }}_{t}} for lateral motion is generally 0.0087 rad/s with probable dependence on deviation from the fovia and movement orientation,[32] velocity is in terms of the distance units, and zero distance is straight ahead. Far object distances, close set-backs, and low velocities generally lower the salience of lateral motion. Detection with close or null set-back can be accomplished through the pure scale changes of looming motion.[34]

The motion acuity limit affects radial motion in accordance to its definition, hence the ratio of the velocity v to the radius R must exceed t {displaystyle {dot {theta }}_{t}} :

Radial motion is encountered in clinical and research environments, in dome theaters, and in virtual-reality headsets.

Follow this link:
Visual acuity - Wikipedia

Read More...

Are opticians open and can you get an eye test? – Metro.co.uk

June 1st, 2020 6:47 pm

Can you see an optician at this time? (Picture: Getty Images)

Speculation over whether coronavirus can affect your eyesight has been rife since Dominic Cummings claimed he made a trip to Barnard Castle during lockdown amid concerns Covid-19 had affected his eyesight.

Boris Johnson has also suggested his vision had been affected by the virus, after saying in Mondays press briefing that he has had to wear glasses for the first time in years.

All of which may have left others wondering about their own vision, and whether it might have been affected but can you currently go to an optician for an eye test?

Heres what you need to know

Visit our live blog for the latest updates: Coronavirus news live

All routine eye tests have been suspended in the wake of lockdown so if you had an eye test booked chances are it wont have happened.

However, some opticians have remained open during this time, with the Government having classed them as being among essential services but only to provide urgent or emergency care where needed, to alleviate pressure on GPs, hospital eye departments and A&E departments.

SpecSavers are among those who have kept some of their branches open for this but have emphasised on their website they have only remained open when it is safe for both our customers and colleagues.

Vision Express are also open for urgent and emergency appointments, with Asda Opticians and Boots Opticians and among others who have remained open for this purpose only but not all branches are open.

In all cases, you are advised not to visit an optician directly, but to to call your local branch if you have a problem, so they can assess your situation and whether or not you need to be seen face to face, either at their branch if its open, or elsewhere.

If your local optician is an independent or belongs to another chain you should also call first to discuss the nature of the problem, and to confirm whether they are open for appointments at this time.

To view this video please enable JavaScript, and consider upgrading to a webbrowser thatsupports HTML5video

An urgent or emergency appointment is classed as one where you might need immediate clinical help such as having red eyes, contact lens discomfort, a foreign object in the eye, a sudden change in vision or unexpected flashers or floaters in the eye.

If your glasses or contact lenses are broken and you need replacements, most opticians are currently delivering these to peoples homes free of charge, so that they do not have to visit the branch to collect them.

MORE: Passenger with poor eyesight killed by train after falling from platform

Follow Metro across our social channels, on Facebook, Twitter and Instagram.

Share your views in the comments below.

Read more:
Are opticians open and can you get an eye test? - Metro.co.uk

Read More...

Are opticians open during lockdown? Latest UK coronavirus opening rules for Boots, Specsavers and Vision Express explained – inews

June 1st, 2020 6:47 pm

NewsHealthLatest UK coronavirus opening rules for Boots Opticians, Specsavers and Vision Express explained

Wednesday, 27th May 2020, 3:41 pm

After Prime Minister Boris Johnson and his chief aide Dominic Cummings claimed that having coronavirus affected their eyesight, people may be keen to get their own eyes checked after recovering from the virus.

Lockdown restrictions in the UK are now beginning to slowly ease, with England moving into phase 2 of lockdown from 1 June.

Non-essential shops are being allowed to reopen from 15 June, but does this include opticians? And what should you do if you have an eye care emergency?

Heres what you need to know.

When did opticians close?

Opticians ceased running routine appointments when the UK entered into lockdown.

When will opticians reopen?

Routine appointments remain suspended in England, Scotland, Northern Ireland and Wales, but those who need essential and urgent eye care can still access help.

What is essential eye care?

This includes, but is not limited to appointments for patients who would not normally be considered to be emergencies, but where a delay in an examination could be detrimental to a patients sight or wellbeing.

This could include situations where patients have broken or lost their glasses or contact lenses and need a replacement pair to function.

What is urgent or emergency eye care?

This is where urgent clinical advice or intervention is needed, e.g. for red eye, contact lens discomfort, foreign objects, sudden change in vision, flashes and floaters, or where the patient has been advised to attend a practice by NHS 111 or another healthcare professional for urgent eye care.

Which opticians are offering emergency eye care?

Specsavers has suspended all routine eye appointments, but the CEO John Perkins, said: We will though still remain open to support people in the communities we work in if they need urgent or essential care.

However, not all stores are open during this time and some of their stores have changed their normal working hours.

The Specsavers website explains that if youre having any problems with your eyes, the best thing to do is to call your local store, who will ask you some questions about your symptoms and will be able to arrange either an essential appointment, over the phone or with their RemoteCare service.

They will then let you know whether you should come into store for an urgent appointment.

They may even refer to you to an eye emergency department. If you do need to come into store, the chain is following government guidelines to make this as safe as possible.

Vision Express, Asda Opticians and Boots Opticians have also remained open for urgent and emergency appointments, but again, not all branches are open.

You are advised to call your local branch if you have a problem, so the optician can assess your situation and whether or not you need to be seen face to face.

See the original post:
Are opticians open during lockdown? Latest UK coronavirus opening rules for Boots, Specsavers and Vision Express explained - inews

Read More...

Sofia Vergara reveals losing her eyesight when she turned 40 – PINKVILLA

June 1st, 2020 6:47 pm

Actress Sofia Vergara says she started losing her eyesight when she turned 40-years-old.

Vergara said she refused to wear glasses because she thought she looked old, reports aceshowbiz.com.

"When I turned 40, 41, 42, I started losing my sight. It's the normal thing that happens at that age. I refused to wear glasses because I felt old. I was like, 'No, I'm going to hold it. I don't need them. I don't need them'," she told people.com.

"We're going to have to use them no matter what at this age, so at least use something that makes you look cute, not like you're the little grandma."

"Those little ones at the top of your nose make you look like a granny if you're reading or something. And I hate that. I prefer the ones that are bold and already a statement, not tiny little things that sit on your nose."

The "Modern Family" actress says amid lockdown she has been reading a lot more."Now that I am home reading so much more, I know how important they are to so many of us. I also know a woman wants to feel good when wearing them, wherever she is. I wanted to offer fashionable, chic, fresh eyewear styles, allowing women to not just to see, but to see beautifully."

The proceeds from sales will benefit Foster Grant's RestoringVision charity.

Also ReadSofia Vergara all set to judge America's Got Talent

x Your comment has been submitted to the moderation queue

More here:
Sofia Vergara reveals losing her eyesight when she turned 40 - PINKVILLA

Read More...

Dominic Cummings may have broken Highway Code with test drive to Barnard Castle, former top police chief says – Evening Standard

June 1st, 2020 6:47 pm

The latest headlines in your inbox twice a day Monday - Friday plus breaking news updates

Dominic Cummings may have broken the Highway Code by driving to Barnard Castle to test his vision, a senior ex-police officer has said.

Former Greater Manchester Police chief constable Sir Peter Fahy said the journey to the town, which Mr Cummings has said was to test his eyesight ahead of a longer journey back to London , was "ill-advised" and potentially put others in danger.

Sir Peter, who was head of Prevent from 2010 to 2015, also said he believed that Mr Cummings may have been sent back to London if he had been stopped by police on his drive up to Durham.

He added that officers are frustrated by the actions of the Prime Minister's chief adviser , amid concerns of "confusion" around reasons to travel.

The intervention comes as the government tries to shift the focus away from the row about Mr Cummings trip to Durham during the coronavirus lockdown.

Dominic Cummings gave a press conference on Monday amid a row over his journey to Durham (AFP via Getty Images)

Asked if Mr Cummings would have been sent home if an officer had stopped him on his way to Durham, Sir Peter told BBC Radio 4s Today programme: I think at that point, in terms of what was the understanding of the regulations and the Government messaging, I think it may well be that absolutely hed have been turned back, as many other people were turned back from things that they were doing.

He was then asked about Mr Cummings's drive to Barnard Castle. During an unprecedented press conference on Monday, Mr Cummings said he drove his family to the town - which was around 25 miles away from where he was self-isolating - to test his eyesight to see if he could make the trip back down to London, 15 days after he had displayed symptoms. He said he had some eyesight problems during his illness.

We did not visit the castle, we did not walk around the town, he insisted, but said that he had felt a bit sick so they had walked about 10 to 15 metres to the riverbank where they sat for about 15 minutes until he felt better.

Sir Peter Fahy, chief constable of Greater Manchester Police (Picture: PA)

On the trip, Sir Peter said: "Clearly, number one, that's ill-advised as a means of testing your eyesight as to whether you're fit to drive, but again it's hard to see - unless there's some justification that that was to take daily exercise - how that was justified."

Pressed on whether if it was a criminal offence, Sir Peter replied: "It certainly appears to be against the Highway Code, it's not the way to test your eyesight, and put potentially other people in danger."

Sir Peter also said it was now hard to see the role of police going forward, adding: The rules about the reasons for travel are now very confused. When you see the crowds on Bournemouth and Southend beaches and other places yesterday, its hard to see what role the police have in trying to control that.

He added: "There's a lot of confusion and it feels like there's quite a gap between the public narrative and narrative of ministers about the lockdown and what's happening on the street.

Mr Cummings said he believed he had acted "reasonably" and legally when he drove 260 miles from home in March.

He said he made the journey because of fears over a lack of childcare if he became incapacitated with the virus, and concerns about his familys safety.

Mr Cummings declined to apologise for his actions but conceded reasonable people may well disagree about how I thought about what to do in the circumstances.

Government minister Michael Gove was asked about Mr Fahys comments and replied: Ive got great respect for Peter Fahy but I think that weve already heard differing accounts of what the police did and didnt do in this affair.

He also added: Whats clear is [Mr Cummings] didnt break the law, he didnt break the rules, he sought to protect his family and he also sought to ensure that the risk of anyone in his family infecting anyone else as absolutely minimised.

See the article here:
Dominic Cummings may have broken Highway Code with test drive to Barnard Castle, former top police chief says - Evening Standard

Read More...

Younger eyes for an aging population with this innovative intraocular lens – Innovation Origins

June 1st, 2020 6:47 pm

After a successful research phase, a new type of Accommodating Intraocular Lens (AIOL) capable of effectively treating presbyopia is looking for a place in the market. Scientists from the Spanish National Research Council (CSIC) are hoping to have the first pre-commercial prototype ready by 2026.

The technology behind this innovative AIOL was revealed in a study published last year in the Optica journal brought out by the Optical Society of America (OSA). Susana Marco, from the Daza Valds Optical Institute of the CSIC, led the team in this ambitious project.

Presbyopia is an age-related condition involving the loss of the crystalline lenss ability to focus after it becomes stiffer with time. This creates difficulties for the eye to properly fixate on either nearby or faraway objects and see them clearly. However, despite affecting 100% of humans over 45 years of age, there is still no satisfactory solution to this condition.

But this might change soon!

The Spanish research team is bringing an intraocular lens that can reshape itself inside the eye and thereby focus on far or near objects, mimicking the ability of a young eye. This is something that has never been done before.

The potential of this optical technology lies not only in the innovative mechanism that sets it apart from any other intraocular lens on the market but also in its capacity to improve the quality of life for those greatly affected by presbyopia.

The team is planning to set up a company in order to bring this to the market Lightlens that aims to commercialize the product. While this has not been completed as yet, the scientists have already started receiving funding to further develop the patented technology.

We are currently talking to different intraocular lens manufacturing companies who could be potential investors and partners. We will set up the company as soon as we have secured financing, Marco said.

Alongside her, the co-inventors of the two patents involved in this research are Carlos Dorronsoro from the CSICs Institute of Optics, and Irene Kochevar from the Wellman Center for Photomedicine at the Massachusetts General Hospital (University of Harvard). Other collaborators include Rocio Gutierrez and Andrs de la Hoz also from the Institute of Optics in Spain.

Marco explained to Innovation Origins that two elements are responsible for the lens capacity being able to adapt and accommodate various distances. The first one produces refraction, which is mainly responsible for the focus on faraway objects. The second is a flexible part that alters the shape of the lens by changing its curvature, which allows it to adapt and fixate properly on any nearby items.

The lens works by changing its curvature to accommodate far and near objects, just like young eye do, added the Spanish scientists.

The way in which its elements come into play is quite straightforward: the lens captures the movement of a muscle in the eye and adjusts itself accordingly. Specifically, it catches the ciliary muscles force, which is the one responsible for dealing with objects at various distances.

The tricky part was how to attach the intraocular lens to the eye so that its mechanism would be sensitive to the movement of the muscles. The answer was found in a photo-adhesive technique, which is a process that involves a photoinitiator agent that is activated by light and enables bonding of the eye with the lens.

According to Marcos, this underlines the success of the lens, as the technique has never been used before to treat presbyopia.

She added that the biggest challenge her team underwent in order to create the technology, was combining all the disciplines that were necessary for its success. The lens uses elements of optomechanical design, photochemical techniques for photoactivation of the bonding process, surgical techniques for implantation, and a material with the relevant optical and mechanical properties.

All elements needed to work smoothly with one another, and in the end, they did.

The result is a never-before-seen technology that is capable of successfully recreating in aging humans the functional capacities of young eyes.

Commercially, the intraocular lens would enter the segment of the sector known as premium. This refers to intraocular lenses that not only correct the crystallines opacification but also improve the patients quality of life and sight. In this case, by recovering their sights ability to accommodate distances, Marco stated.

The lens was first designed through a computational process. After that, prototypes were manufactured and tested in an eye stretcher (equipment optimized for eye surgery, ed) which had a system installed that replicated the ciliary muscles movement. The photochemical bonding was demonstrated initially outside the context of an eye and then surgically inside the eyes of a porcine animal model.

According to Marco, before implantation in humans, it is necessary to adjust some design parameters so that biocompatibility and toxicity tests, as well as preclinical tests, can be carried out on animal models and then in clinical trials with human patients. She emphasized that the lens is still under development and that other tests are necessary to ensure an optimal and safe outcome.

The current challenge with the LightLens is that it is not only an intraocular lens, but that it is also particularly sophisticated, with new elements in its design, with new substances in its material, and it uses light in its application.

In the past, the team behind Lightlens has had experience in commercializing other optical products. They founded 2EyesVision, Plenoptika, and PhysIOL; all of which are looking to improve ophthalmological processes.

Marco is very positive about the future of LightLens. She concluded that their aim is to provide patients with a solution that replicates the functioning of the young eye, which will, without a doubt, improve their quality of vision and their quality of life.

See more here:
Younger eyes for an aging population with this innovative intraocular lens - Innovation Origins

Read More...

Current Trends: Eyesight Test Equipment Market 2020: What are the key opportunities? – Cole of Duty

June 1st, 2020 6:47 pm

Trending Eyesight Test Equipment Market: Covid-19 Outbreak Impact Analysis

Toronto, Canada: The global Eyesight Test Equipment Market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Researchs latest publication, titled global Eyesight Test Equipment market, offers an insightful take on the drivers and restraints present in the market. It assesses the historical data pertaining to the global Eyesight Test Equipment market and compares it to the current market trends to give the readers a detailed analysis of the trajectory of the market.

Top Key players cited in the report: EyeNetraBhavana MDCEssilor InternationalAlcon, Inc.HeineHeidelberg Engineering GmbHSeiko Optical Products Co., Ltd.Nidek Co., Ltd.Carl Zeiss AGHoya CorporationAbbott Medical Optics.Inc.Johnson & Johnson Vision Care.Inc.Shenzhen Certainn Technology

Get Free PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart)

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Eyesight Test Equipment Market which would mention How the Covid-19 is Affecting the Eyesight Test Equipment Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Eyesight Test Equipment Players to Combat Covid-19 Impact.

The research report covers the trends that are currently implemented by the major manufacturers in the Eyesight Test Equipment market including adoption of new technology, government investments on R&D, shifting in perspective towards sustainability, and others. Additionally, the researchers have also provided the figures necessary to understand the manufacturer and its contribution to both regional and global market:

The research report is broken down into chapters, which are introduced by the executive summary. Its the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the global Eyesight Test Equipment market includes Porters five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

Segmentation by Type:

PortableStationary

Segmentation by Application:

ChildrenAdultsThe Elder

The chapter on regional segmentation details the regional aspects of the global Eyesight Test Equipment market. It highlights the political scenario in the market and the anticipates its influence on the global Eyesight Test Equipment market.

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (the United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

The report answers important questions that companies may have when operating in the global Eyesight Test Equipment market. Some of the questions are given below:

What will be the size of the global Eyesight Test Equipment market in 2025? What is the current CAGR of the global Eyesight Test Equipment market? Which product is expected to show the highest market growth? Which application is projected to gain a lions share of the global Eyesight Test Equipment market? Which region is foretold to create the most number of opportunities in the global Eyesight Test Equipment market? Will there be any changes in market competition during the forecast period? Which are the top players currently operating in the global Eyesight Test Equipment market? How will the market situation change in the coming years? What are the common business tactics adopted by players? What is the growth outlook of the global Eyesight Test Equipment market?

The scope of the Report:

The report segments the global Eyesight Test Equipment market on the basis of application, type, service, technology, and region. Each chapter under this segmentation allows readers to grasp the nitty-gritties of the market. A magnified look at the segment-based analysis is aimed at giving the readers a closer look at the opportunities and threats in the market. It also address political scenarios that are expected to impact the market in both small and big ways.The report on the global Eyesight Test Equipment market examines changing regulatory scenario to make accurate projections about potential investments. It also evaluates the risk for new entrants and the intensity of the competitive rivalry.

Grab Best Discount on Eyesight Test Equipment Market Research Report [Single User | Multi User | Corporate Users] @ https://www.supplydemandmarketresearch.com/home/contact/1201758?ref=Discount&toccode=SDMRLI1201758

Table of Contents

Report Overview: It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Eyesight Test Equipment market segments by application, study objectives, and years considered.

Global Growth Trends: This section has three chapters- Industry Trends, Growth Rate of Major Producers and Production Analysis.

Eyesight Test Equipment Market Share by Manufacturer: Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, Distribution of products, service areas and headquarters provided by major manufacturers.

Market Size by Type: This includes price analysis by type, production value market share, and production market share.

Market Size by Application: This section includes Eyesight Test Equipment market consumption analysis by application.

Profiles of Manufacturers: Here, leading players of the global Eyesight Test Equipment market are studied based on sales area, key products, gross margin, revenue, price, and production.

Eyesight Test Equipment Market Value Chain and Sales Channel Analysis: It includes customer, distributor, Eyesight Test Equipment market value chain, and sales channel analysis.

Market Forecast: Production aspects: In this part of the report, the author focused on predicting production and production value, forecasting the main producers, and predicting production and production value by production type.

About Us:We have a strong network of high powered and experienced global consultants who have about 10+ years of experience in the specific industry to deliver quality research and analysis. Having such an experienced network, our services not only cater to the client who wants the basic reference of market numbers and related high growth areas in the demand side, but also we provide detailed and granular information using which the client can definitely plan the strategies with respect to both supply and demand side.

Contact Us: Nimesh H302-20 Misssisauga, Valley, Missisauga,L5A 3S1, Toronto, Canada Phone Number: +1-276-477-5910Email- [emailprotected]

View post:
Current Trends: Eyesight Test Equipment Market 2020: What are the key opportunities? - Cole of Duty

Read More...

Coronavirus in Scotland RECAP: death toll reaches 2,291 as hospitalisations fall by 69 – Scotland on Sunday

June 1st, 2020 6:47 pm

There is little evidence to link Covid-19 to eyesight problems, the Royal College of Ophthalmologists and Moorfields Eye Hospital have said.

Downing Street aide Dominic Cummings said on Monday that he drove to Barnard Castle with his wife and child in order to test his eyesight before making the drive back home to London.

He was backed up by Prime Minister Boris Johnson, who suggested he too had suffered problems with his vision after contracting coronavirus.

Mr Johnson told the daily Downing Street briefing on Monday: Im finding I have to wear spectacles for the first time in years, I think because of the effects of this thing.

So Im inclined to think thats very, very plausible, that eyesight can be a problem associated with coronavirus.

Moorfields Eye Hospital said on Tuesday there was little evidence at the moment of a link and said more data was needed.

A statement said: At present, there is very little evidence to suggest that Covid-19 can affect eyesight.

Cases where Covid-19 is recorded alongside an impact on eyesight are rare, so we cannot establish a direct causal effect.

We need more data to be collected on Covid-19-related eye conditions to see if there is an association.

The Royal College of Ophthalmologists also said it was unable to report on the link due to a lack of evidence.

A statement said the College is unable to report on the association of vision impairment, as a result of a patient contracting Covid-19, due to a lack of evidence.

A direct causal effect can only be established through the reporting of proven cases of Covid-19 patients and their symptoms.

The College said its scientific journal, Eye, has recently published a collection of research papers looking at Covid-19 patients and eye health.

One of these papers points to potential problems experienced by some patients in intensive care, including corneal infection, inability to close the eyes and the eye surface becoming very dry.

The College said: We believe that there have been a few cases reported on viral conjunctivitis and a statement was issued on this topic, in association with the College of Optometrists, in March.

But Robert MacLaren, professor of ophthalmology at the University of Oxford, said coronavirus can affect the eyes in several ways.

It was reported in approximately one third of patients in Wuhan (China) in a recent study.

The ocular manifestations in the Wuhan patients included conjunctivitis, conjunctival hyperemia (red eye), chemosis (eye swelling), epiphora (watery eye) and increased secretions (sticky eye).

Any of the above symptoms may affect vision and affected patients would be advised to drive with caution or not at all if there was significant blurring of vision or double vision.

See the original post:
Coronavirus in Scotland RECAP: death toll reaches 2,291 as hospitalisations fall by 69 - Scotland on Sunday

Read More...

Molecular Genetics Company MiraDx Offers COVID-19 Viral Testing To U.S. Universities and Colleges – Business Wire

June 1st, 2020 6:45 pm

LOS ANGELES--(BUSINESS WIRE)--MiraDx, a Los Angeles-based molecular genetics company that transitioned its CLIA-certified lab to provide COVID-19 tests for essential workers, is now expanding access to its PCR viral testing to public and private universities and colleges across the country. MiraDx aims to enable students, faculty, and staff to resume on-campus education later this year in an environment that provides a clear framework and easy and comprehensive access to highly accurate testing for the COVID-19 virus.

MiraDx is able to develop testing programs customized to the needs of an individual institution. Notably, the MiraDx lab, which is now exclusively processing COVID-19 tests, has dedicated reserved capacity for college programs, both to optimize turnaround time and mitigate the backlog many other labs are currently experiencing. With specific days allocated to individual schools, MiraDx will be able to deliver test results back to school officials through a secure server within 48 hours of receipt at the lab.

Accurate and sensitiveCOVID-19 testing of all Americans is of the utmost importance, said Dr. Joanne Weidhaas, co-founder of MiraDx. As our company continues to provide testing for thousands of first responders and essential workers, we have also turned our attention to another matter of national importance: enabling our youth to continue their on-campus education as safely and as soon as possible. Our goal is to contribute in a meaningful way to institutions of higher learning to allow students, faculty, and staff to return to campus in good health and give parents peace of mind that their children are safe.

MiraDxs discussions with over 100 schools across the country, along with guidance from health officials, have helped to inform the development of emerging testing protocols, to include day one clearance testing of the entire student body and faculty, followed by repeat sentinel testing throughout the semester.

We are focused on delivering the highest quality, most sensitive and dependable testing programs possible, said Dr. Weidhaas, herself an educator at UCLA. We are only going to commit to programs today we know we can achieve in the fall we are not going to sell capacity we do not have, and in fact, we are building in a buffer of capacity in each college testing day.

MiraDx has a CLIA-certified lab with a high complexity molecular processing designation that allows it to conduct PCR testing, a highly sensitive approach that results in over 90 percent accuracy in COVID-19 testing and is considered the gold standard in testing. To determine whether an individual is infected with COVID-19, a sample is collected from a swab of the back of the throat, where the highest viral load exists for this coronavirus. The MiraDx test includes an air-tight vial, collection swab, a biohazard bag, and simple instructions for collecting the sample, which is collected under the supervision of a healthcare professional. MiraDxs analysis technique can identify as little as four copies of COVID-19 RNA in an individual sample, meaning that the virus can be detected even during the early stages of infection and/or in asymptomatic individuals. Non-PCR based testing approaches are either less sensitive (resulting in more false negatives) or do not tell patients when they are no longer contagious, which either leaves them in quarantine too long or presents the risk of them coming out of quarantine too soon.

MiraDxs COVID-19 test has been developed in line with the FDAs Emergency Use Authorization requirements.

About MiraDx

Dr. Joanne Weidhaas, MD, PhD, MSM is the co-founder of MiraDx and a professor and vice-chair in the department of radiation oncology at UCLA.

MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer treatment, and now performs COVID-19 testing. Its goal is to improve human health and advance personalized medicine through the application of novel functional germline biomarkers. To learn more about MiraDx, please visit miradx.com. Please send inquiries to info@miradx.com

Read the original here:
Molecular Genetics Company MiraDx Offers COVID-19 Viral Testing To U.S. Universities and Colleges - Business Wire

Read More...

Western Pa. experts weigh chances of catching coronavirus from contaminated objects – TribLIVE

June 1st, 2020 6:45 pm

TribLIVE's Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox.

Fears about catching coronavirus from contaminated surfaces have driven some people to become compulsive about cleaning countertops and wiping down their groceries. As the pandemic took hold, some poison centers even reported increased calls about excessive exposure to cleaning agents.

In recent weeks, the Centers for Disease Control and Prevention appeared to adjust its stance on surface transmission of the coronavirus. New language on its website was interpreted as deemphasizing concerns, creating some confusion about the risk of catching covid-19 from frequently touched objects.

Pittsburgh-based infectious disease and critical care physician Dr. Amesh Adalja said that while the contact spread of the virus can certainly occur, it is not responsible for the bulk of transmission.

Weve always known that there is a small contribution from contaminated surfaces. I think the CDC guidance reflects the fact that were trying to focus on the main route of how this virus gets from person to person. It is from another person directly, Adalja said. Our public health strategy needs to be focused on eliminating the person-to-person spread,and there can be less emphasis on contact spread.

After some news outlets ran with the idea that the CDC was no longer concerned about surface transmission, the agency issued a statement clarifying that contact with a contaminated surface is still one way to catch covid-19.

It may be possible that a person can get covid-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose or possibly their eyes. But this isnt thought to be the main way the virus spreads, the statement said. The change on the website was intended to make it easier to read, and was not a result of any new science.

Dr. Arvind Venkat, an Allegheny Health Network emergency physician, observed that we live in a hyper-connected world, and social media can create controversies that arent always there. So, the combination of not having consistent communication and an environment in which everything is so fragmented is a bad combination in a public health crisis.

Venkat also past president of the Pennsylvania College of Emergency Physicians said public health authorities must communicate carefully and accurately to maintain trust with the public.

Since this is a new virus, were still learning as we go along. The fact that there is contradictory and changing data is to be expected, Venkat said. So, when something changes, we need to make sure that we convey that in a systematic way so that it doesnt get perceived as going back and forth.

So, what are the chances of catching covid-19 from an object or surface laden with germs?

I think the relative risk of picking it up from common things given the precautions that everybody is taking is much lower, said Seema Lakdawala, assistant professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine.

But if you are a health care worker and you are working in a hospital setting with patients that are symptomatic and coughing and sneezing large volumes of the virus into their environment then, yes, the risk of catching it from a surface is much higher.

The feeling among medical experts who spoke with the Tribune-Review is people are unlikely to catch the virus from doing things like grocery shopping. Lakdawala, an expert in virus transmission, said she does not wipe down her groceries.

Everyone has their own comfort level. If somebody is taking the time to wipe down every single material three times, I would say that is a waste of their time, Lakdawala said. I think its important for the general public to understand, What kind of information do I need to make a risk assessment for myself?

Adalja said that while its important for people to continue to take protective action, they can be a little less concerned about contaminated surfaces they may have touched.

I think people can be less worried about making sure they scrub their groceries. Thats less likely to be impactful than other things, like washing your hands and trying to avoid crowded spaces and other social-distancing measures.

Paul Guggenheimer is a Tribune-Review staff writer. You can contact Paul at 724-226-7706 or pguggenheimer@triblive.com.

Categories:Coronavirus | Editor's Picks | Health | Local | Allegheny | Top Stories

TribLIVE's Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox.

Read this article:
Western Pa. experts weigh chances of catching coronavirus from contaminated objects - TribLIVE

Read More...

All About the Twisted Story Behind Motive for Murder – E! NEWS

June 1st, 2020 6:45 pm

AP Photo/Crime Stoppers via Houston Chronicle, File

The case almost went cold for good.

On Jan. 15, 2012, Gelareh Bagherzadeh was sitting in the driver's seat of her silver Nissan Altima when she was shot twice in the head, point blank, from the passenger side of her car. She had been talking to a friend, who heard her scream, then silence, and called 911. Gelareh's cell phone was found at her feet. The car had smashed into the garage of a townhouse, one in a row behind The Galleria, an upscale mall in Houston, and the acrid smell of burnt tire rubber was thick in the air.

Her purse and wallet were there, seemingly intact, so it didn't appear to be a robbery. There were no signs of sexual assault.

It was a mystery, one thathad enough twists and turnsto end up the subject ofDateline and NBC News' latest true crime podcast, Motive for Murder.

"I'm no stranger to mystery, to secrets people are desperately trying to hide, and the things those people are willing to do to get what they want," Motive for Murderhost and longtimeDateline correspondent Josh Mankiewiczexplained as episode one got underway.

**This is documented real life, and Dateline covered the case in 2019,sothis isn't exactly a SPOILERalert, but there are major revelations about the case ahead.

An early theory that turned the story into national news was that perhaps Gelareh's outspoken political views had gotten her killed. Perhaps the Iranian government was involved.

The 30-year-old had moved to Houston from her native Iran for school and was studying molecular genetics at the University of Texas MD Anderson Cancer Center when she was killed. But she remained plugged in to the troubles at home andshe took part in protests in Houston supporting theIranian Green Movement, which disputed the legitimacyof then-President Mahmoud Ahmadinejad's re-election in 2009 and was demanding regime change.

Her activism certainly worried her parents, Ebrahim Bagherzadeh and Monireh Zangeneh, but they remembered their daughter being unafraid of any potential consequencesthough, according to the Houston Chronicle, she had asked that her name not be used when the paper posted a video from a 2010 protest on its website.

Friends in Gelareh's inner circle were skeptical, however, that the Iranian government would "waste their energy and time" by orchestrating the death of a student activist all the way in Texas. Though "if they had...they would take credit for it" to warn off other dissidents, observed Gelareh's close friend, Kathy Soltis.

Local police said early on that they didn't suspect either apoliticalmotive or that she was targeted because of her ethnicity.

Fingerprints found on the car, the bullets recovered at the scene, a cigarette butt on the ground outside the car doorall were sent to the lab for forensic testing.

Dead ends, the lot.

In the meantime, detectives started probing the possibility that the motive had something to do with one of three overarching motives for so many murders: love, money or pride.

Houston PD homicide investigator DetectiveRichard Bolton, now retired, recalled to Mankiewicz the inevitable part of the probe when they looked into the men in Gelareh's life, including her fairly new boyfriend, Cory Beavers, and the friend who said he heard a scream on the phone seemingly seconds before she was shot,Robeen Bandarwho also was her ex-boyfriend.

Bandar explained (to police and Mankiewicz) thatthey had had an amicable breakup and had mutually decided they would be better off just being friends.

Police asked why heheard a scream but didn't recallhearinga gun shot or screeching tires. Bandar said it was probably shock or denial of what he may indeed have heard.

Onto Gelareh's current boyfriend, Cory, the last known person to see her alive.

He told police that she had surprised him by showing up at his house, but he had a test to study for so they only hung out for awhile. When sheleft, he told her to text him when she got home to let him know she had arrived safely. He never heard from or saw her again.

Cory said he didn't know Gelareh was dead until he drove up to her house the next day and a reporter approached him and asked if he knew anything about "the girl who lived here."

He knocked on the door and Ibrahim answered, and he was the one to tell Cory that Gelareh was dead.

Police also looked intocrimes with similar M.O.s in the area, wondering if she was the victim of a carjacking gone wrong. They looked at a lawsuit her father was embroiled in at the time with a former employer.

More dead ends.

Four months after the murder, police announced that the family was offering a $200,000 reward for information that led to justice for Gelareh, the largest Crime Stoppers reward on offer in the country at the time.

The dozen or so tips that merited follow-up also led nowhere. But then there was another shooting that November.

The victim was Cory Beavers' identical twin brother, Coty. And homicide detectives don't put much stock in coincidences.

Coty Beavers' wife, Nesreen Irsan,had called 911 to report that her boyfriend had been shot. "Why did God do this to me?"she's heard wailing on the call.

She had found her husband's body in their apartment when she returned home from work. She told police she last saw Coty that morning, when he walked her down to her car to see her off, as he usually did. When police responded to her 911 call, it was apparent he had been dead for awhile. It was later determined that his wedding ring had been moved from his ring finger to the middle finger of his left hand.

Coty and Nesreen were newlyweds. According to Cory, Nesreenalso a student at MD Anderson, like Cory and Gelarehwas originally interested in him, but Cory was determined to keep his mind on his studies and introduced Nesreen to Coty. Nesreen was friends withGelareh, meanwhile, and she's the one who introduced her to Cory after he saw the two of them walking together at school. He was smitten immediatelyand after talkingto her more at a party not long after, they started dating.

By the time his newlywed brother was killed, Corystill reeling from the murder of his girlfriendwas fed up with what he felt was time wasted by the police looking at him as a suspect and any other activity that didn't get them any closer to finding Gelareh's killer.

Nesreen, meanwhile, had her own traumatic past. In the summer of 2011 she had run away from her strict Muslim household and her controlling father, whom she described as "violent and abusive," with only the clothes she was wearing. She climbed out of a window and went to a neighbor's house and asked for a rideto Coty and Cory's mom Shirley Beavers' house in Spring, Texas.

Nesreen had been dating Coty and keeping it a secret from her father, Ali Irsan, with the help of her sister Nadiawho would simultaneously cover for Nesreen but also threaten to tell on her.

When Ali Irsan found out about Nesreen and Coty, he barred his 23-year-old daughter from leaving the house.

Mayra Beltran/Houston Chronicle via AP

Police had no recourse to bring Ali's adult daughter back to their house if she didn't want to be there, so Ali showed up at Shirley's house himself (how he found out where they lived,whether the address was online or Nadia told him, or whatever, they didn't know). Ali knocked on their neighbors' doors, offering $100 for information on Coty's whereabouts. In the ensuing days, the Beavers would go outside in the morning to find that the air had been let out of their tires, so they had to start moving their cars. An order of protection Nesreen obtained against her father didn't stop himbut that at least paved the way for police to obtain a warrant to search the Irsan family's home, as well as two other properties Ali owned. They found a dismantled hand gun.

Cory recalled to Mankiewicz a fight he witnessed between Nadia and Nesreen during college, ostensibly over a petty issue,in which Nadia told her sister, "'I can't wait until my dad puts a bullet in your head.'"

"I believed her," Cory said.

Melissa Phillip/Houston Chronicle via AP, File

Going through boxes of documents they'd confiscated, police found paperwork that indicated Ali Irsan was committing multiple acts of fraud, such as falsely claiming disability benefits and opening credit cards in his kids' names.

Sothe Harris County Sheriff's Department brought in theFBI, and ultimately a task force thatcame to includethe Montgomery and Harris County sheriff offices, the FBI, the Houston Police Department, the Social Security Administration Office and Homeland Security got to work.

According to authorities, Irsan, a naturalized citizen, had first come to the U.S. from Jordan in 1978 and proceeded to marry a blind woman whom he physically and sexually abused, and had four children with. While still married, he brought a teenage bride, Shmou, over from Jordan, and they had eight more children, including Nesreen and Nadia.

In 2014, Irsan was chargedin federal court with conspiracy to defraud the United States, theft of public money and benefits fraud, and Shmou and Nadia were arrested, too. In April 2015, he pleaded guiltyto conspiracy to defraud and was sentenced to 45 months in prison; his wife and daughterwere convicted of providing false statements as part of the fraud schemeand were each sentenced to two years in prison.

But back to the double murder investigation.

Yet another thing discovered in the course of the investigation into Irsan was the revelation that he had been pulled over by a Texas State Trooper on the day of Gelareh's murder. His wife and one of his sons were also in the cara silver Toyota Camry.

Which, incidentally, matched the description given by a witness back in 2012 who told police she saw what looked to be a silver Camry speeding away from the site of the shooting. Nothing had ever come of it.

The location and timing of the traffic stop put Irsan's car exactly where it would have been had he driven away from the crime scene after the shooting. Dash-cam footage showed Ali barely able to stand, and he told the trooper hewas diabetic and suffering from low blood sugar, so he had been speeding on his way to find sugar.

There was no evidence that he was a diabetic.

It was almost a fluke that the trooper still had the dash-cam footage after two years. According to Mankiewiecz, the officer just had a funny feeling about the guy...

Furthermore, per authorities and Cory Beavers, it turned out that Gelareh and Alihad crossed pathstheir seeming lack of interaction having been a nagging issue when trying to connect Ali to both her murder and that of his son-in-law.

AfterNesreen fled her family's home in 2011, Ali started calling her classmates under the guise of simply being a concerned dad.

Gelareh wasn't having it, and told him she saw right through what he was trying to do.

Toward the end of the year, he called again. Gelareh called back and first talked to Nadia, who then passed the phone to her father, who asked (according to Cory), "Is this that Iranian bitch?" Gelareh proceeded to tell him off in Farsi. He hung up. A few weeks later she was dead.

In May 2014, Ali Irsan was charged with Gelareh's murder. That charge would be dropped for tactical reasons, because once authorities had connected him to both killings, Irsan was charged in 2015 with capital murder, for what has since been characterized as two so-called "honor killings."

Or make that three. In 1999, Irsan fatally shot his 29-year-old son-in-law Amjad Alidam. He told police Alidam had been abusing his daughter, and he killed him in self-defense. Authorities later said they couldn't build a case to prove otherwise.

In 2018, jurors spent 35 minutes deliberating before convicting him of themurders of Gelareh Bagherzadeh and Coty Beavers.

During the penalty phase of the trial, a former neighborsaidthat Ali Irsan hadbragged to him that he "got away with murder" inthe death of his other son-in-law."He said he invited his son-in-law to his house and shot him," the witness, Randy Wilkinson, testified. "He said he shot him with a 12-gauge shotgun and planted a gun on him."

His sonNasim Irsan, the one who was in the Camry with him, pleaded guilty in both murders as well and was sentenced last August to 40 years in prison. Ali Irsan iscurrently on death row in Texas.

The finale ofMotive for Murderwill be outThursday, June 4, wherever you get your podcasts.

(E! and NBC News are both members of the NBCUniversal family.)

Link:
All About the Twisted Story Behind Motive for Murder - E! NEWS

Read More...

Page 519«..1020..518519520521..530540..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick